Lv4
518 积分 2022-11-23 加入
Unlocking biological barriers: nonclinical safety considerations for RNA-based complex biologics
22天前
已完结
Unlocking biological barriers: nonclinical safety considerations for RNA-based complex biologics
28天前
已完结
Unlocking biological barriers: nonclinical safety considerations for RNA-based complex biologics
28天前
已关闭
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
2个月前
已完结
Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1
4个月前
已关闭
不同周龄、性别、环境下SD大鼠自发病变的病理学研究
7个月前
已完结
Recommendations of the Oligonucleotide Safety Working Group's Formulated Oligonucleotide Subcommittee for the Safety Assessment of Formulated Oligonucleotide-Based Therapeutics
8个月前
已完结
Alkaline Phosphatases: Biochemistry, Functions, and Measurement
9个月前
已完结
Targeting both death and paracaspase domains of MALT1 with antisense oligonucleotides overcomes resistance to immune-checkpoint inhibitors
10个月前
已完结
皖公网安备34019202002308
